Skip to main content
OpenTrials

Clinical trial condition

High-grade Ta/ T1 Papillary Disease Bladder Cancer

Explore clinical trials studying High-grade Ta/ T1 Papillary Disease Bladder Cancer. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

High-grade Ta/ T1 Papillary Disease Bladder Cancer trial results

Recruiting

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

NCT07283835

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +15 more
Locations
  • Peking University First Hospital (First Clinical Medical School of Peking University) Beijing, Beijing Municipality, China
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
View all 14 locations
View Trial Details
Active, Not Recruiting

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

NCT04452591

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +15 more
Locations
  • Urology Centers Alabama Homewood, Alabama, United States
  • BCG Oncology Phoenix, Arizona, United States
  • Mayo Clinic Cancer Center Phoenix, Arizona, United States
  • Arizona Institute of Urology Tucson, Arizona, United States
View all 86 locations
View Trial Details

Related conditions